- Home
- ASM vs ALMS Comparison
ASM vs ALMS Comparison
Compare ASM & ALMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASM
- ALMS
- Stock Information
- Founded
- ASM 1968
- ALMS 2021
- Country
- ASM Canada
- ALMS United States
- Employees
- ASM N/A
- ALMS N/A
- Industry
- ASM Metal Mining
- ALMS
- Sector
- ASM Basic Materials
- ALMS
- Exchange
- ASM Nasdaq
- ALMS NYSE
- Market Cap
- ASM 252.5M
- ALMS 260.6M
- IPO Year
- ASM N/A
- ALMS 2024
- Fundamental
- Price
- ASM $1.88
- ALMS $5.64
- Analyst Decision
- ASM Strong Buy
- ALMS Strong Buy
- Analyst Count
- ASM 2
- ALMS 7
- Target Price
- ASM $2.00
- ALMS $28.17
- AVG Volume (30 Days)
- ASM 3.2M
- ALMS 1.2M
- Earning Date
- ASM 03-11-2025
- ALMS 05-15-2025
- Dividend Yield
- ASM N/A
- ALMS N/A
- EPS Growth
- ASM 1287.60
- ALMS N/A
- EPS
- ASM 0.06
- ALMS N/A
- Revenue
- ASM $66,178,000.00
- ALMS N/A
- Revenue This Year
- ASM $24.16
- ALMS N/A
- Revenue Next Year
- ASM $21.17
- ALMS N/A
- P/E Ratio
- ASM $32.88
- ALMS N/A
- Revenue Growth
- ASM 50.78
- ALMS N/A
- 52 Week Low
- ASM $0.59
- ALMS $3.18
- 52 Week High
- ASM $2.00
- ALMS $13.53
- Technical
- Relative Strength Index (RSI)
- ASM 62.86
- ALMS N/A
- Support Level
- ASM $1.77
- ALMS N/A
- Resistance Level
- ASM $1.96
- ALMS N/A
- Average True Range (ATR)
- ASM 0.15
- ALMS 0.00
- MACD
- ASM 0.01
- ALMS 0.00
- Stochastic Oscillator
- ASM 82.35
- ALMS 0.00
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.